Pasi A. Jänne

Pasi A. Jänne is Professor of Medicine at Harvard Medical School and Senior Vice President for Translational Medicine at Dana-Farber Cancer Institute, where he holds the David M. Livingston, MD Chair. He directs the Belfer Center for Applied Cancer Science and Chen-Huang Center for EGFR Mutant Lung Cancers.

Medical degree and PhD from University of Pennsylvania (1996), residency at Brigham and Women's Hospital, and fellowship at Dana-Farber Cancer Institute.

Research focuses on therapeutic targeting of oncogenic alterations in lung cancer. Co-discovered EGFR mutations and developed corresponding therapeutic strategies, significantly advancing lung cancer treatment paradigms.

Clinical practice specializes in thoracic oncology with emphasis on EGFR-targeted therapies and translational approaches.

Awards include:

• American Cancer Society Medal of Honor (2024)
• Léopold Griffuel Prize (2022)
• NCI Outstanding Investigator (2018)
• ESMO Translational Research (2018)
• AACR Waun Ki Hong Award (2018)

Leads multiple research teams at Belfer Center developing novel cancer therapies through integrated basic-translational approaches.